This content is only available within our institutional offering.
01 Mar 2020
CMD should be a positive catalyst
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
CMD should be a positive catalyst
Although Lerøy’s Q4/19 results fell 4% short of consensus expectations, their outlook comments should provide support to our expectations of improved operational performance from 2021. We also expect to get further visibility on volume growth and cost improvements at their Capital Markets Day in May/June this year. We still see Lerøy as our preferred stock in the sector, raise our target price to NOK 70 (65) and reiterate our Buy rating.